Drug Screening Market Growth, Analysis Report, Share, Trends and Overview 2022-2031 | LabCorp, Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc.

The global drug screening market was valued at USD 5.6 billion in 2021 and it is expected to reach up to USD 25.3 billion by 2031, at a CAGR of 16.3% during the projection period.

New York, According to a new market research report published by Global Insight Services Drug Screening Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

View Detailed Report Description : https://www.globalinsightservices.com/reports/drug-screening-market/

Drug screening is the process of recognizing illicit and some recommended drugs in the blood, urine, and other biological samples. A drug screening process is also called the analysis and detection of performance-enhancing drugs consumed by professional athletes like steroids and HGH in order to improve stamina and performance at the time of the sport.

The rising incidence of such drugs consumptions across the world is the major concern being faced by many governments. For example, according to National Institute on Drug Abuse (NIDA), in 2010, an estimated 22.6 million of the population were illicit drug users in the U.S, which accounted for an estimated 8.9% of the total population of the country.

Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS10273

Market Trends and Drivers

The key factor boosting the growth of the market is growing drug and alcohol consumption. Drug abuse and alcohol consumption are increasing worldwide. According to the World Drug Report 2021, in 2019, an estimated 275 million people across the globe aged 15-64, or 1 in every 18 people in that age group, have used drugs at least once in the previous year. In the same year, drug use killed almost half a million people, while drug use disorders resulted in 18 million years of healthy life lost, mainly owing to opioids. Alcohol consumption has shown similar increases, with consequences witnessed in the growing incidence of impaired driving. The increasing consumption of illicit drugs & alcohol will further boost the development of drug screening products & services on the road, thereby driving the overall market growth.

Get a 50% Off on Purchase of this Report Use Code (GIS2022SUP50) : https://www.globalinsightservices.com/checkout/single_user/GIS10273

Market Restraints and Challenges

The key factor hindering the growth of the market is the prohibition of workplace drug testing in some countries. Some countries like Canada, Colombia, Argentina, Chile, and South Africa, consider drug & alcohol testing at the workplace to be a violation of employee privacy. For example, pre-employment drug testing is only performed in France when physicians recommend the test. In Poland and the Czech Republic, drug & alcohol tests in the workplace are prohibited. In Canada, the Eastern Canadian case laws permit drug & alcohol testing only when workplace operations are fundamentally dangerous or where drug and alcohol testing is limited to a few special cases. Such prohibitions in various countries may hamper the adoption of drug & alcohol testing in these markets, so restraining overall market growth to a certain extent.

Major Players in the Global Drug Screening Market

The key players studied in the global drug screening market are LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies, Inc. (US), Siemens Healthineers (Germany), Roche (Switzerland), MPD Inc. (US), Shimadzu (Japan), LifeLoc Technologies (US), Drägerwerk (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics (US), Clinical Reference Laboratory (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), CareHealth America Corp (US), Sciteck, Inc. (US), Synens (France), Intoximeters (US), AccuSource (US), Cordant Health Solutions (US), Millennium Health (US).

Request For Customization : https://www.globalinsightservices.com/request-customization/GIS10273

Reasons to buy Drug Screening Market Report:

• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.